{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Becatecarin",
  "nciThesaurus": {
    "casRegistry": "119673-08-4",
    "chebiId": "",
    "chemicalFormula": "C33H34Cl2N4O7",
    "definition": "A synthetic diethylaminoethyl analogue of the indolocarbazole glycoside antineoplastic antibiotic rebeccamycin.  Becatecarin intercalates into DNA and stabilizes the DNA-topoisomerase I complex, thereby interfering with the topoisomerase I-catalyzed DNA breakage-reunion reaction and initiating DNA cleavage and apoptosis. ",
    "fdaUniiCode": "A60X6MBU6G",
    "identifier": "C1620",
    "preferredName": "Becatecarin",
    "semanticType": "Antibiotic",
    "subclassOf": [],
    "synonyms": [
      "1,11-Dichloro-6-[2-(diethylamino)ethyl]-12,13-dihydro-12-(4-O-methyl-beta-D-glucopyranosyl)-5H-indolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7(6H)-dione",
      "5H-Indolo(2,3-a)pyrrolo(3,4-c)carbazole-5,7(6H)-dione, 1,11-dichloro-6-(2-(diethylamino)ethyl)-12,13-dihydro-12-(4-O-methyl-beta-D-glucopyranosyl)-",
      "BECATECARIN",
      "BMS-181176",
      "BMY-27557-14",
      "Becatecarin",
      "DEAE-Rebeccamycin",
      "NSC 655649",
      "Rebeccamycin Analogue",
      "Rebeccamycin Analogue, Tartrate Salt",
      "Rebeccamycin analog",
      "XL119",
      "rebeccamycin analog"
    ]
  }
}